TANDEM DIABETES CARE INC·4

Aug 11, 6:15 PM ET

Sheridan John F 4

4 · TANDEM DIABETES CARE INC · Filed Aug 11, 2025

Insider Transaction Report

Form 4
Period: 2025-08-11
Sheridan John F
DirectorPRESIDENT & CEO
Transactions
  • Purchase

    Common Stock

    2025-08-11$10.23/sh+10,000$102,318106,327 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $10.19 to $10.33 per share. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    wk-form4_1754950540.xmlPrimary

    FORM 4